Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 19 results for "zanamivir"

New and Generic Drug Approvals: Relenza

Drug Name(s) RELENZA FDA Application No. (NDA) 021036 Active Ingredient(s) ZANAMIVIR Company GLAXOSMITHKLINE Original Approval or Tentative Approval Date July 26, 1999 Chemical Type 1New molecular entity (NME) Review Classification ... U.S. Food and Drug Administration, 1 day ago

2 images for "zanamivir"

CNN, 1 month ago
CNN, 1 month ago

Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses

† CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing 100101, China‡ National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Normal ...
 Journal of Medicinal Chemistry2 weeks ago

New Cell Study Presents Groundbreaking Pre-Clinical Work: Developing Immune Therapy to Potentially Treat Serious Influenza A

Details Category: Antibodies Published on Friday, 22 July 2016 16:10 Hits: 9 MEDI8852 blocked all influenza A with unique binding properties Gaithersburg, MD, USA I July 21, 2016 I A paper published today by Cell presents pre-clinical work to ...
 PipelineReview2 days ago

EPIDEMIOLOGY OF INFLUENZA

Upcoming SlideShare Loading in … 5 1. DR. . maheswarijaikumar2103@gmail.com 2. INFLUENZA • Influenza is an acute respiratory tract infection caused by INFLUENZA VIRUS (which is of 3 types) : A, B, and C. 3. • At present three types of ...
 SlideShare.net5 days ago Influenza Remains A Threat Unaddressed: 500 Thousand People Hospitalized Every Year  I2Mag2 months ago
MedIndia

Acute Bronchitis

Acute bronchitis, commonly known as a chest cold, is a short-term inflammation of lower respiratory tract affecting the air tubes (bronchi) of the lungs. The upper airways consisting of the nose and throat lead to the trachea or windpipe. The ...
 MedIndia3 weeks ago

Global Systemic Antiviral Pharmaceuticals Market Current Trends/Opportunities/Challenges

Global Systemic Antiviral Pharmaceuticals Market Antiviral drugs are a class of medication that inhibits the development of infection causing viruses. Like antibiotics, specific antiviral drugs are used against specific viruses. As viruses share ...
 MyNewsDesk1 month ago Systemic Antiviral Pharmaceuticals Market - Global Industry Research 2016 to 2023  Press Release Ping1 month ago

Influenza Activity — United States, 201516 Season and Composition of the 201617 Influenza Vaccine

/ 65(22);567575 Stacy L. Davlin, PhD1,2; Lenee Blanton, MPH1; Krista Kniss, MPH1; Desiree Mustaquim, MPH1; Sophie Smith, MPH1; Natalie Kramer1; Jessica Cohen, MPH1,2; Charisse Nitura Cummings, MPH1,3; Shikha Garg, MD1; Brendan Flannery, PhD1; ...
 Center for Disease Control and Prevention1 month ago

Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus

Abstract In order to better understand inflammation associated with influenza virus infection, we measured cell trafficking, via flow cytometry, to various tissues in the ferret model following infection with an A(H3N2) human seasonal influenza ...
 Plosone.org1 month ago

Patent Issued for Cap/Endo Dual Inhibitors and Their Use in the Treatment, Amelioration Or Prevention of a Viral Disease (USPTO 9359351)

By a News Reporter-Staff News Editor at -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Schulz-Gasch, Tanja (Ziefen, CH); Weikert, Robert ( Basel, CH); Neidhart, Werner ...
 Equities.com1 month ago Patent Issued for Prophylactic/Therapeutic Agent for Influenza Virus Infection (USPTO 9351949)  4 Traders1 month ago

Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016

Takashita E, Ejima M, Itoh R, Miura M, Ohnishi A, Nishimura H, etal. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Euro Surveill. 2014;19(1):20666.
 Eurosurveillance1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less